by Gabriela Colmenares | Dec 20, 2018 | GNAO1 |
As discussed in a previous post, we are currently working on a GNAO1 PerlQuest collaboration with the Undiagnosed Diseases Network (UDN) and Harvard Medical School. GNAO1 is a gene that encodes for the alpha subunit of a G protein, and mutations in this gene lead a...
by Feba Sam | Jul 10, 2018 | Science |
At Perlara, we work to find therapeutics for rare genetic diseases. We develop and use immunoassays, phase contrast imaging, as well as enzymatic assays, in order to screen thousands of compounds and obtain hits from cell readouts to complement our model organism...
by Naz Dana | Jun 20, 2018 | Business |
Starting this month, we are going to use our blog to update you on upcoming events – be they conferences that Perlara team members are participating in, or events that may be of interest to the life sciences community at large. In addition, we will include...
by Aras Rezvanian | May 23, 2018 | Science |
One of the rare genetic disorders that we at Perlara have been working on is Mucolipidosis type IV (MLIV) – one of the Mucolipidosis group of inherited lysosomal storage disorders. For background on MLIV, and to learn more about our work in optimizing a MLIV drug...
by Tamy Portillo Rodriguez | Nov 1, 2017 | Perlara science |
Perlara’s high throughput screen progress in Mucolipidosis IV (MLIV) flies… In this blog post, I’ll tell you about Perlara’s high throughput screen progress in MLIV flies. Last year, Tom Hartl reviewed some details of MLIV disease biology and described how...
